文献速递乳腺技术与安全US

基于超声影像组学列线图预测早期乳腺癌腋窝淋巴结转移

Ultrasound-based radiomics nomogram for predicting axillary lymph node metastasis in early-stage breast cancer.
PubMed 文献 · Radiol Med · 2024-01-27

本研究纳入755例早期乳腺癌患者(原发队列527例,外部验证队列228例),基于超声图像提取瘤内及不同瘤周区域影像组学特征,构建「肿块+瘤周3mm」模型并联合临床特征建立列线图,原发队列和外部验证队列AUC分别为0.906和0.922,列线图区分阳性与阴性淋巴结的AUC为0.853和0.870。

要点

  • 「肿块+瘤周3mm」影像组学模型表现最佳,列线图原发队列AUC 0.906、外部验证队列AUC 0.922。
  • 列线图区分阳性与阴性淋巴结的原发队列AUC 0.853、验证队列AUC 0.870。
  • 列线图区分低容量与高容量淋巴结的原发队列AUC 0.832、验证队列AUC 0.911。

核心结论

  • 建立的列线图是一种用于无创评估腋窝淋巴结状态的前瞻性临床预测工具,能够提高早期乳腺癌治疗的准确性。

研究设计与样本

  • 研究纳入755例患者,其中原发队列527例、外部验证队列228例,均采集超声图像并对瘤内及不同瘤周区域进行影像组学分析。
  • 在原发队列提取的特征上采用MRMR和LASSO回归分析构建影像组学特征公式并结合临床特征,用Pearson系数和方差膨胀因子(VIF)检查最终预测因子间的相关性和多重共线性。
  • 选择表现最佳的模型通过二元逻辑回归建立列线图,并基于肿块对应的列线图评分获取截断值。

诊断标准与关键数值

  • 在所有影像组学模型中,「肿块+瘤周3mm」模型表现最佳,列线图在原发队列和外部验证队列的AUC分别为0.906(95%CI 0.882-0.930)和0.922(95%CI 0.894-0.960),两者均显示良好校准。
  • 列线图区分阳性与阴性淋巴结的AUC在原发队列为0.853(95%CI 0.816-0.889),在验证队列为0.870(95%CI 0.818-0.922)。
  • 列线图区分低容量与高容量淋巴结的AUC在原发队列为0.832(95%CI 0.781-0.884),在验证队列为0.911(95%CI 0.858-0.964)。

临床应用与阅片要点

  • 原文结论认为该列线图是用于无创评估腋窝淋巴结状态的前瞻性临床预测工具,可提高早期乳腺癌治疗的准确性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We aimed at assessing the predictive ability of ultrasound-based radiomics combined with clinical characteristics for axillary lymph node (ALN) status in early-stage breast cancer patients and to compare performance in different peritumoral regions.

MATERIALS AND METHODS: A total of 755 patients (527 in the primary cohort and 228 in the external validation cohort) were enrolled in this study. Ultrasound images for all patients were acquired and radiomics analysis performed for intratumoral and different peritumoral regions. The MRMR and LASSO regression analyses were performed on extracted features from the primary cohort to construct a radiomics signature formula combined with clinical characteristics. Pearson's coefficient and the variance inflation factor (VIF) were performed to check the correlation and the multicollinearity among the final predictors. The best performing model was selected to develop a nomogram, which was established by performing binary logistic regression and acquiring cut-off values based on the corresponding nomogram scores of the masses.

RESULTS: Among all the radiomics models, the "Mass + Margin3mm" model exhibited the best performance. The areas under the curves (AUC) of the nomogram in the primary and external validation cohorts were 0.906 (95% confidence intervals [CI] 0.882-0.930) and 0.922 (95% CI 0.894-0.960), respectively. They both showed good calibrations. The nomogram exhibited a good ability to discriminate between positive and negative lymph nodes (AUC: 0.853 (95% CI 0.816-0.889) in primary cohort, 0.870 (95% CI 0.818-0.922) in validation cohort), and between low-volume and high-volume lymph nodes (AUC: 0.832 (95% CI 0.781-0.884) in primary cohort, 0.911 (95% CI 0.858-0.964) in validation cohort).

CONCLUSIONS: The established nomogram is a prospective clinical prediction tool for non-invasive assessment of ALN status. It has the ability to enhance the accuracy of early-stage breast cancer treatment.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Zhang W, Wang S, Wang Y, et al. Ultrasound-based radiomics nomogram for predicting axillary lymph node metastasis in early-stage breast cancer. Radiol Med. 2024. PMID: 38280058. doi:10.1007/s11547-024-01768-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。